In utero exposure to ADHD medication and long-term offspring outcomes-Reference-Cited by-同舟云学术

In utero exposure to ADHD medication and long-term offspring outcomes

Published:2023-02-09 Issue:4 Volume:28 Page:1739-1746
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Bang Madsen Kathrine^ORCID,Robakis Thalia K.^ORCID,Liu Xiaoqin,Momen Natalie^ORCID,Larsson Henrik^ORCID,Dreier Julie Werenberg,Kildegaard Helene^ORCID,Groth Jane Bjerg,Newcorn Jeffrey H.^ORCID,Hove Thomsen Per,Munk-Olsen Trine,Bergink Veerle

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

Sygeforsikring "danmark" is a large Danish Foundation NIHM National Institute of Mental Health is the National US foundation

Det Frie Forskningsråd

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

https://www.nature.com/articles/s41380-023-01992-6.pdf

Reference39 articles.

1. Franke B, Michelini G, Asherson P, Banaschewski T, Bilbow A, Buitelaar JK, et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol. 2018;28:1059–88.

2. Zetterqvist J, Asherson P, Halldner L, Långström N, Larsson H. Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009. Acta Psychiatr Scand. 2013;128:70–7.

3. Anderson KN, Ailes EC, Danielson M, Lind JN, Farr SL, Broussard CS, et al. Attention-deficit/hyperactivity disorder medication prescription claims among privately insured women aged 15–44 years - United States, 2003–2015. Morb Mortal Wkly Rep. 2018;67:66–70.

4. Haervig KB, Mortensen LH, Hansen AV, Strandberg-Larsen K. Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register-based study. Pharmacoepidemiol Drug Saf. 2014;23:526–33.

5. Lemelin M, Boukhris T, Zhao J-P, Sheehy O, Bérard A. Prevalence and determinants of attention-deficit/hyperactivity disorder (ADHD) medication use during pregnancy: results from the Quebec Pregnancy/Children Cohort. Pharmacol Res Perspect. 2021;9:e00781.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attention-deficit/hyperactivity disorder in pregnancy and the postpartum period;American Journal of Obstetrics and Gynecology;2024-07

2. Prescription psychostimulant use, admissions and treatment initiation and retention in pregnant people with opioid use disorder;Nature Mental Health;2024-06-11

3. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children;JAMA Psychiatry;2024-05-01

4. From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care;Journal of Child and Adolescent Psychopharmacology;2024-05-01

5. Amphetamine Exposure during Embryogenesis Alters Expression and Function of Tyrosine Hydroxylase and the Vesicular Monoamine Transporter in Adult C. elegans;International Journal of Molecular Sciences;2024-04-11